1.       Berber E, Çanakoğlu N, Tonbak Ş, et al. Development of a protective inactivated vaccine against Crimean-Congo hemorrhagic fever infection. Heliyon. 2021;7(10):e08161. doi:10.1016/j.heliyon.2021.e08161.

2.       Deyde V, Khristova M, Rollin P, et al. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol. 2006;80(17):8834-8842. doi:10.1128/JVI.00752-06

3.       Elaldi N, Bodur H, Ascioglu S, et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect. 2009;58:238. doi: 10.1016/j.jinf.2009.01.014

4.       Ergonul O, Whitehead CA, eds. Crimean-Congo Hemorrhagic Fever. A Global Perspective. Amsterdam: Springer; 2007.

5.       Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006 Apr;6(4):203-14. doi: 10.1016/S1473-3099(06)70435-2.

6.       Flusin O, Iseni F, Rodrigues R, et al. La fièvre hémorragique de Crimée-Congo: l'essentiel pour le praticien [Crimean-Congo hemorrhagic fever: basics for general practitioners]. Med Trop (Mars). 2010 Dec;70(5-6):429-38. French.

7.       Harik N, Jacobs RF. Nocardia. In: Cherry JD, Harrison GJ, eds. Feigin and Cherry’s Textbook of Pediatric Infectious Diseases. 8th ed. Philadelphia; 2019. p.1013-1016.

8.       Harrison GJ. Crimean-Congo hemorrhagic fever. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, eds. Feigin and Cherry’s Textbook of Pediatric Infectious Diseases. 8th ed. Philadelphia: WB Saunders; 2019. p.1879-82.

9.       Kara Ulu N, Tezer H. Kırım Kongo kanamalı ateşi. Somer A, editör. Çocukluk Çağında Sorunlu Enfeksiyonlar. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.108-115.

10.   Leblebicioglu H, Ozaras R, Fletcher TE, et al; ESCMID Study Group for Infections in Travellers and Migrants (ESGITM). Crimean-Congo haemorrhagic fever in travellers: A systematic review. Travel Med Infect Dis. 2016 Mar-Apr;14(2):73-80. doi: 10.1016/j.tmaid.2016.03.002.

11.   Leblebicioglu H. Crimean-Congo hemorrhagic fever. In: UpToDate, Hirsch MS (Ed), UpToDate (Accessed on September, 2025).

12.   Papa A, Papadimitriou E, Christova I. The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain. Scand J Infect Dis. 2011;43(3):225-9. doi: 10.3109/00365548.2010.540036.

13.   Sall A, Thonnon J, Sene O, et al. Single-tube and nested reverse transcriptase polymerase chain reaction for detection of Rift Valley fever virus in human and animal sera. J Virol Methods. 2001;91:85-92. doi: 10.1016/s0166-0934(00)00252-4

14.   Savaş Şen Z, Polat M. Kırım-Kongo kanamalı ateşi. Tezer H, editör. Çocuklarda Zoonotik Hastalıklar. 1. Baskı. Ankara: Türkiye Klinikleri; 2022. p.25-30.

15.   T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, Zoonotik ve Vektörel Hastalıklar Dairesi Başkanlığı. Kırım-Kongo kanamalı ateşi (Hekimlere Yönelik). 2020.
https://hsgm.saglik.gov.tr/depo/birimler/zoonotik-vektorelhastaliklar-db/zoonotik-hastaliklar/1-KKKA/7-Sunumlar/KKKA_Sunum_Hekimlere_Ynelik08.04.2020.pdf

16.   Tezer H, Sucakli IA, Sayli TR, et al. Crimean-Congo hemorrhagic fever in children. J Clin Virol. 2010;48:184-186. doi:10.1016/j.jcv.2010.04.001

17.   Watts DM, Ksiazek TG, Linthicum KJ, et al. Crimean-Congo hemorrhagic fever. In: Monath TP, ed. The Arboviruses: Epidemiology and Ecology. Vol. 2. Boca Raton, Fla.: CRC Press; 1989:177-222.

18.   Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64(3):145-160. doi:10.1016/j.antiviral.2004.08.001

19.   WHO. Crimean-Congo hemorrhagic fever.
http://www.who.int/mediacentre/factsheets/fs208/en/ (accessed Feb 17, 2006).

20.   Yilmaz M, Aydin K, Akdogan E, et al. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever. J Clin Virol. 2008;42:415-417. doi:10.1016/j.jcv.2008.03.003